01
ONCOLOGY
Oncology &
Supportive Care
We develop innovative approaches designed to address serious complications associated with intensive cancer treatment and supportive care.
ADVANCING BIOPHARMACEUTICAL SCIENCE
Pioneering Solutions for Critical Needs
DOR BioPharma is a late-stage biopharmaceutical company focused on transformative scientific programs across oncology, gastrointestinal research, supportive care, and biodefense.
SCIENTIFIC DEVELOPMENT
03
Core Focus Areas
∞
Scientific Potential
WHO WE ARE
Science with a purpose.
At DOR BioPharma, innovation is driven by the opportunity to address complex clinical challenges through focused research, scientific collaboration, and disciplined development.
Our programs bring together scientific expertise and clinical perspective to advance approaches intended to make a meaningful difference for patients and communities.
OUR FOCUS
Three Areas of
Scientific Focus
Our development activities span multiple areas where innovative biopharmaceutical approaches can contribute to important clinical needs.
Oncology &
02
GASTROINTESTINAL
Gastrointestinal
Research
Our research programs focus on serious gastrointestinal conditions and areas where significant unmet clinical needs remain.
Acute GI GVHD
Pediatric Crohn’s Disease
Inflammatory Bowel Diseases
03
BIODEFENSE
Biodefense
Solutions
Our scientific activities include biodefense programs supporting preparedness and protection against serious biological threats.
OUR MISSION
Advancing science through integrity and innovation.
DOR BioPharma is committed to developing life-saving biopharmaceutical solutions through advanced science, clinical excellence, and a patient-first approach.
We believe meaningful innovation comes from combining rigorous scientific development with collaboration and a clear understanding of important unmet needs.
OUR APPROACH
01 — 04
01
Patient-Centric
Keeping patient needs at the center of scientific development.
02
Scientific Excellence
Applying rigorous science throughout research and development.
03
Clinical Perspective
Connecting scientific innovation with meaningful clinical needs.
04
Collaboration
Working with researchers and institutions to advance discovery.
INNOVATION
From scientific ideas
to meaningful impact.
Our development philosophy combines focused research, collaboration, clinical insight, and a commitment to scientific progress.
Transformative Biopharmaceutical Development
Our work is centered on developing innovative approaches for serious conditions and challenging clinical situations. We seek opportunities where focused scientific development can create meaningful advances.
01
Focused Research
02
Clinical Excellence
03
Scientific Collaboration
RESEARCH
Evidence-led development
Building programs around scientific rigor and continuous learning.
COLLABORATION
Partnership-driven progress
Connecting expertise across researchers and institutions.
01
OUR COMMITMENT
Innovation that begins with real-world needs.
Since our inception, DOR BioPharma has been guided by a commitment to excellence, innovation, and patient-centered scientific development.
We combine advanced research with clinical perspective to pursue solutions in areas where significant challenges remain.
OUR JOURNEY
Milestones That
Shape Our Journey
Key moments reflecting the company's development, research initiatives, and continuing scientific focus.
2011
OCTOBER 11
RESEARCH INITIATIVE
Pediatric Crohn’s Disease Advisory Board
Formation of a Pediatric Crohn’s Disease Medical Advisory Board to help guide future research and scientific development.
2011
AUGUST 12
COMPANY DEVELOPMENT
Second-Quarter Milestones
Announcement of second-quarter financial results and key accomplishments supporting the company's development strategy.
NOW
CONTINUING
ONGOING DEVELOPMENT
Continuing Scientific Development
Continued focus on biopharmaceutical innovation, clinical development, collaboration, and areas of significant unmet need.
PARTNERSHIPS
Partnering for
scientific progress.
DOR BioPharma welcomes collaboration with organizations and experts who share our commitment to advancing innovative scientific programs.
HSC Transplantation
Collaboration opportunities involving hematopoietic stem cell transplantation research and supportive care.
Supportive Care
Scientific programs addressing important challenges associated with intensive cancer treatment.
Gastrointestinal Research
Collaborative opportunities across gastrointestinal research and development programs.
Biodefense
Partnerships supporting scientific preparedness and biodefense research initiatives.
DOR BIOPHARMA
Building the future
of biopharmaceutical science.
Explore our scientific focus, development programs, and opportunities for collaboration.
Explore Our Science →